283 related articles for article (PubMed ID: 29631376)
1. Insulin-like growth factor-binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.
Austin K; Tsang D; Chalmers JA; Maalouf MF; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G206-G219. PubMed ID: 29631376
[TBL] [Abstract][Full Text] [Related]
2. IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine.
Austin K; Imam NA; Pintar JE; Brubaker PL
Endocrinology; 2015 Feb; 156(2):429-36. PubMed ID: 25514089
[TBL] [Abstract][Full Text] [Related]
3. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.
Fesler Z; Mitova E; Brubaker PL
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32147716
[TBL] [Abstract][Full Text] [Related]
4. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
Liu X; Murali SG; Holst JJ; Ney DM
Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
[TBL] [Abstract][Full Text] [Related]
5. Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.
Murali SG; Brinkman AS; Solverson P; Pun W; Pintar JE; Ney DM
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G794-804. PubMed ID: 22281475
[TBL] [Abstract][Full Text] [Related]
6. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
Hembree JR; Agarwal C; Eckert RL
Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells.
Simmons JG; Hoyt EC; Westwick JK; Brenner DA; Pucilowska JB; Lund PK
Mol Endocrinol; 1995 Sep; 9(9):1157-65. PubMed ID: 7491108
[TBL] [Abstract][Full Text] [Related]
9. Aspartame supplementation in starter accelerates small intestinal epithelial cell cycle and stimulates secretion of glucagon-like peptide-2 in pre-weaned lambs.
Sun D; Liu L; Mao S; Zhu W; Liu J
J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1338-1350. PubMed ID: 31342562
[TBL] [Abstract][Full Text] [Related]
10. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat.
Markovic MA; Srikrishnaraj A; Tsang D; Brubaker PL
FASEB J; 2020 May; 34(5):6628-6640. PubMed ID: 32212202
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.
Nelson DW; Murali SG; Liu X; Koopmann MC; Holst JJ; Ney DM
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1175-84. PubMed ID: 18256135
[TBL] [Abstract][Full Text] [Related]
12. Effects of insulin, insulin-like growth factors and epidermal growth factor on mitogenesis and disaccharidase activity in rat (IEC-6) and human (FHs 74 Int) intestinal cells.
Chao JC; Donovan S
Chin J Physiol; 1996; 39(4):253-63. PubMed ID: 9058010
[TBL] [Abstract][Full Text] [Related]
13. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
Dong CX; Zhao W; Solomon C; Rowland KJ; Ackerley C; Robine S; Holzenberger M; Gonska T; Brubaker PL
Endocrinology; 2014 Feb; 155(2):370-9. PubMed ID: 24265452
[TBL] [Abstract][Full Text] [Related]
14. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.
Taqi E; Wallace LE; de Heuvel E; Chelikani PK; Zheng H; Berthoud HR; Holst JJ; Sigalet DL
J Pediatr Surg; 2010 May; 45(5):987-95. PubMed ID: 20438940
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.
Dubé PE; Rowland KJ; Brubaker PL
Endocrinology; 2008 Jan; 149(1):291-301. PubMed ID: 17884945
[TBL] [Abstract][Full Text] [Related]
16. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Dubé PE; Forse CL; Bahrami J; Brubaker PL
Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
[TBL] [Abstract][Full Text] [Related]
17. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
18. Regulation of insulin-like growth factor (IGF)-binding protein expression by growth factors and cytokines alters IGF-mediated proliferation of postnatal lung fibroblasts.
Price WA
Exp Lung Res; 2004 Jun; 30(4):261-83. PubMed ID: 15204833
[TBL] [Abstract][Full Text] [Related]
19. EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I.
Takaoka M; Smith CE; Mashiba MK; Okawa T; Andl CD; El-Deiry WS; Nakagawa H
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G404-16. PubMed ID: 16210470
[TBL] [Abstract][Full Text] [Related]
20. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
